Key Clinical Formulas & Scores
Eye: 4=Spontaneous, 3=To speech, 2=To pain, 1=None
Verbal: 5=Oriented, 4=Confused, 3=Inappropriate, 2=Incomprehensible, 1=None
Motor: 6=Obeys commands, 5=Localizes pain, 4=Withdraws, 3=Flexion, 2=Extension, 1=None
Score: 13-15=Mild, 9-12=Moderate, 3-8=Severe (coma)
1a: Level of consciousness (0-3)
1b: LOC questions (0-2)
1c: LOC commands (0-2)
2: Best gaze (0-2)
3: Visual fields (0-3)
4: Facial palsy (0-3)
5-6: Motor arm/leg (0-4 each)
7: Limb ataxia (0-2)
8: Sensory (0-2)
9: Best language (0-3)
10: Dysarthria (0-2)
11: Extinction/inattention (0-2)
Interpretation: 0=no stroke, 1-4=minor, 5-15=moderate, 16-20=moderate-severe, 21-42=severe
A = Age β₯60 years (1 pt)
B = BP β₯140/90 (1 pt)
C = Clinical features: Unilateral weakness (2), speech impairment (1)
D = Duration: β₯60 min (2), 10-59 min (1)
Dβ = Diabetes (1 pt)
Score 0-3: Low risk (1.0% 2-day stroke risk)
Score 4-5: Moderate (4.1%)
Score 6-7: High (8.1%)
0 = No symptoms
1 = No significant disability (able to carry out all usual activities)
2 = Slight disability (unable to carry out all previous activities, but able to look after own affairs)
3 = Moderate disability (requires some help, but able to walk unassisted)
4 = Moderately severe disability (unable to walk unassisted, unable to attend to bodily needs)
5 = Severe disability (bedridden, incontinent, requires constant care)
6 = Dead
β’ GCS 3-4: 2 points
β’ GCS 5-12: 1 point
β’ GCS 13-15: 0
β’ ICH volume β₯30 mL: 1 point
β’ ICH volume <30 mL: 0
β’ Intraventricular hemorrhage: Yes=1, No=0
β’ Infratentorial origin: Yes=1, No=0
β’ Age β₯80: Yes=1, No=0
30-day mortality: 0=13%, 1=26%, 2=72%, 3=97%, 4=100%, 5=100%
Core Concepts
Stroke: Ischemic vs Hemorrhagic
Ischemic (87%): Thrombotic, embolic, or hypoperfusion. CT: hyperdense artery sign, loss of gray-white differentiation, insular ribbon sign. Treatment: IV tPA within 4.5 hours (0.9 mg/kg, max 90mg), mechanical thrombectomy within 6-24 hours (based on DAWN/DEFUSE-3 criteria). Hemorrhagic (13%): hypertensive (basal ganglia, thalamus, pons, cerebellum), aneurysmal SAH, AVM. CT: hyperdense blood. Reverse coagulization, lower SBP <140, neurosurgical evaluation.
Seizure Classification & Management
ILAE 2017: Focal (aware/impaired awareness), Generalized (absence, myoclonic, atonic, tonic-clonic), Unknown. Status epilepticus: seizure >5 min or recurrent without recovery. First-line: lorazepam 0.1 mg/kg IV (max 4mg) or midazolam 10mg IM. Second-line: levetiracetam 60 mg/kg IV or fosphenytoin 20 mg PE/kg. Third-line: propofol or midazolam infusion. Non-convulsive status: continuous EEG monitoring.
Peripheral Neuropathy Patterns
Mononeuropathy: single nerve (carpal tunnel, ulnar neuropathy). Mononeuritis multiplex: multiple nerves, asymmetric (vasculitis, diabetes). Polyneuropathy: distal symmetric stocking-glove (diabetes, B12 deficiency, alcohol, CMT). Radiculopathy: dermatomal (disc herniation, foraminal stenosis). Plexopathy: brachial/lumbosacral (trauma, tumor, radiation). Nerve conduction studies + EMG for localization and characterization.
Headache Classification (ICHD-3)
Primary: Migraine (with/without aura, chronic), Tension-type (infrequent/frequent/chronic), Cluster (episodic/chronic), Trigeminal autonomic cephalalgias. Secondary: SAH ("thunderclap"), temporal arteritis (>50 yrs, ESRβ, jaw claudication), meningitis, IIH (papilledema, LP opening pressure >25 cmHβO), medication overuse, post-traumatic. SNOOP4 red flags: Systemic symptoms, Neurologic signs, Onset sudden, Older age (>50), Previous headache history change, Positional, Precipitated by Valsalva, Papilledema, Progressive.
Parkinson Disease & Movement Disorders
PD: TRAP symptoms β Tremor (resting 4-6 Hz), Rigidity (cogwheel), Akinesia/Bradykinesia, Postural instability. Pathology: Lewy bodies (Ξ±-synuclein), dopaminergic neuron loss in substantia nigra. Treatment: Levodopa/Carbidopa (gold standard), dopamine agonists (pramipexrole, ropinirole), MAO-B inhibitors (selegiline, rasagiline), COMT inhibitors (entacapone), DBS for advanced disease. Atypical: MSA, PSP, CBD, DLB.
Clinical Case Studies
Case 1: Acute Ischemic Stroke
Patient: 68-year-old male, sudden right-sided weakness and aphasia, last seen normal 2 hours ago. NIHSS = 12. BP 185/100. CT head: no hemorrhage, hyperdense left MCA sign. CT angiography: left M1 occlusion.
Diagnosis: Acute left MCA ischemic stroke, eligible for both IV tPA and mechanical thrombectomy.
Management: IV tPA 81 mg (8.1 mg bolus + 72.9 mg infusion over 1 hour). Mechanical thrombectomy (stent retriever) β door-to-puncture time <90 minutes. Post-procedure: aspirin 325mg daily (after 24h if tPA given), statin, dysphagia screen, DVT prophylaxis, stroke unit admission, rehabilitation.
Case 2: Status Epilepticus
Patient: 45-year-old female, witnessed tonic-clonic seizure lasting 8 minutes, not returning to baseline. PMH: epilepsy, non-compliant with levetiracetam. Glucose 95 mg/dL, Na 138, temp 38.2Β°C.
Diagnosis: Convulsive status epilepticus.
Management: Lorazepam 4mg IV Γ 2 doses. Levetiracetam 60 mg/kg IV load (3000mg). Continuous EEG monitoring. Workup: LP (meningitis/encephalitis?), CT head, labs (CBC, CMP, tox screen, antiepileptic drug levels). If refractory: propofol or midazolam infusion with goal burst suppression on EEG.
Case 3: Subarachnoid Hemorrhage
Patient: 52-year-old female, sudden severe "thunderclap" headache with neck stiffness and photophobia. GCS 14 (E4 V4 M6). CT head: diffuse hyperdensity in basal cisterns and sylvian fissures. Hunt & Hess Grade II.
Diagnosis: Aneurysmal subarachnoid hemorrhage (Fisher Grade 3).
Management: Emergent CTA to identify aneurysm. Neurosurgical consultation for clipping or endovascular coiling. Nimodipine 60mg every 4 hours Γ 21 days (prevents vasospasm). Maintain euvolemia, avoid hypotension. Transcranial Doppler monitoring for vasospasm. Treat hypertension cautiously (target SBP <160). EVD if hydrocephalus.
Practice Questions
A: Severe TBI (GCS 3-8). Requires airway protection (intubation), emergent neuroimaging, ICP monitoring, and neurosurgical consultation.
A: Within 4.5 hours of last seen normal (with extended window up to 4.5 hours for select patients based on imaging criteria).
A: High risk (4.1% 2-day stroke risk). Urgent neurology consultation, MRI brain with DWI, carotid imaging, anticoagulation if confirmed TIA, antiplatelet if not.
A: Benzodiazepines β lorazepam 0.1 mg/kg IV (max 4mg) or midazolam 10mg IM if no IV access.
A: 97-100%. ICH score: GCS 3-4=2, GCS 5-12=1, volume β₯30mL=1, IVH=1, infratentorial=1, age β₯80=1.